UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 157

Sortiert nach

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Cancer cell, 2022-01, Vol.40 (1), p.70-87.e15

2022

Volltextzugriff (PDF)

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Cancer research (Chicago, Ill.), 2018-11, Vol.78 (22), p.6486-6496

2018

Volltextzugriff (PDF)

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

Journal for immunotherapy of cancer, 2019-12, Vol.7 (1), p.341-341, Article 341

2019

Volltextzugriff (PDF)

New hypothesis and treatment targets of depression：an integrated view of key findings

Neuroscience bulletin, 2015-02, Vol.31 (1), p.61-74

2015

Volltextzugriff (PDF)

Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

Clinical cancer research, 2020-07, Vol.26 (14), p.3649-3661

2020

Volltextzugriff (PDF)

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

BMC cancer, 2021-03, Vol.21 (1), p.282-282, Article 282

2021

Volltextzugriff (PDF)

Primary resistance to icotinib in a patient with lung adenocarcinoma harboring EGFR L858R and Q787k mutations

Lung cancer (Amsterdam, Netherlands), 2019-10, Vol.136, p.153-155

2019

Volltextzugriff (PDF)

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

NPJ precision oncology, 2022-01, Vol.6 (1), p.4-4, Article 4

2022

Volltextzugriff (PDF)

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial

BMC medicine, 2022-02, Vol.20 (1), p.42-42, Article 42

2022

Volltextzugriff (PDF)

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer

Therapeutic advances in medical oncology, 2021, Vol.13, p.175883592110384-17588359211038477

2021

Volltextzugriff (PDF)

Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing

Pathology oncology research, 2020, Vol.26 (1), p.109-114

2020

Volltextzugriff (PDF)

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients

Cancer Immunology, Immunotherapy, 2020-03, Vol.69 (3), p.365-372

2020

Volltextzugriff (PDF)

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC

BMC medicine, 2021-10, Vol.19 (1), p.239-239, Article 239

2021

Volltextzugriff (PDF)

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma

Respiratory research, 2023-07, Vol.24 (1), p.176-176, Article 176

2023

Volltextzugriff (PDF)

Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis

Oncotarget, 2017-04, Vol.8 (14), p.22854-22862

2017

Volltextzugriff (PDF)

An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes

Journal of psychopharmacology (Oxford), 2019-10, Vol.33 (10), p.1227-1236

2019

Volltextzugriff (PDF)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study

BMC medicine, 2021-10, Vol.19 (1), p.1-243, Article 243

2021

Volltextzugriff (PDF)

Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer

Frontiers in oncology, 2022-05, Vol.12, p.881953-881953

2022

Volltextzugriff (PDF)

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920936882-1758835920936882

2020

Volltextzugriff (PDF)

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes

BMC medicine, 2022-02, Vol.20 (1), p.64-64, Article 64

2022

Volltextzugriff (PDF)

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence

Journal of psychopharmacology (Oxford), 2018-06, Vol.32 (6), p.691-701

2018

Volltextzugriff (PDF)

Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer

Journal of translational medicine, 2023-03, Vol.21 (1), p.194-194, Article 194

2023

Volltextzugriff (PDF)

Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation

Psychiatry research, 2019-04, Vol.274, p.301-305

2019

Volltextzugriff (PDF)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer

EBioMedicine, 2022-09, Vol.83, p.104222-104222, Article 104222

2022

Volltextzugriff (PDF)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma

Frontiers in oncology, 2023-03, Vol.13, p.1085188-1085188

2023

Volltextzugriff (PDF)

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma

Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

New hypothesis and treatment targets of depression：an integrated view of key findings

Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

Primary resistance to icotinib in a patient with lung adenocarcinoma harboring EGFR L858R and Q787k mutations

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer

Spectrum of Pathogenic Germline Mutations in Chinese Lung Cancer Patients through Next-Generation Sequencing

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma

Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis

An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study

Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence

Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer

Association between symptom control and functional improvement in patients with acute schizophrenia: A post hoc analysis of an open-label, single-arm, multi-center study of paliperidone-extended release formulation

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma

Suchergebnisse filtern